Get the Stockscreener App
3.38
0.88%
-0.03
After Hours:
3.46
0.08
+2.37%
Artelo Biosciences Inc stock is traded at $3.38, with a volume of 20,099.
It is down -0.88% in the last 24 hours and down -40.70% over the past month.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
See More
Previous Close:
$3.41
Open:
$3.42
24h Volume:
20,099
Relative Volume:
0.19
Market Cap:
$2.38M
Revenue:
-
Net Income/Loss:
$-9.60M
P/E Ratio:
-1.0696
EPS:
-3.16
Net Cash Flow:
$-8.96M
1W Performance:
-19.33%
1M Performance:
-40.70%
6M Performance:
-45.31%
1Y Performance:
-51.44%
1-Day Range:
$3.35
$3.605
1-Week Range:
$3.15
$4.335
52-Week Range:
$3.15
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Name
Artelo Biosciences Inc
Sector
Industry
Phone
858-925-7049
Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
3.38 | 6.81M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Feb-12-21 | Initiated | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Stock (ARTL) Latest News
Will Artelo Biosciences Inc. stock benefit from infrastructure spending2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
Artelo Biosciences Inc. stock trend forecastInsider Selling & Weekly High Return Stock Opportunities - newser.com
Earnings visualization tools for Artelo Biosciences Inc.Market Volume Summary & Stock Portfolio Risk Management - newser.com
Is Artelo Biosciences Inc. stock near bottom after declineJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
Will Artelo Biosciences Inc. see short term momentumJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
What is the fair value of Artelo Biosciences Inc. stock nowInsider Selling & AI Powered Trade Plan Recommendations - newser.com
Is Artelo Biosciences Inc. stock gaining market shareJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Is Artelo Biosciences Inc. building a consolidation baseQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
How to track smart money flows in Artelo Biosciences Inc.Breakout Watch & Capital Efficient Trade Techniques - newser.com
Real time scanner hits for Artelo Biosciences Inc. explainedTrade Ideas & Fast Moving Trade Plans - newser.com
Is Artelo Biosciences Inc. stock a safe haven asset2025 Market Overview & Smart Allocation Stock Reports - newser.com
What recovery options are there for Artelo Biosciences Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Is Artelo Biosciences Inc. showing signs of accumulation2025 Performance Recap & Verified Trade Idea Suggestions - newser.com
Can Artelo Biosciences Inc. stock surprise with earnings upsideQuarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Is Artelo Biosciences Inc. still worth holding after the dipMarket Performance Report & AI Powered Market Entry Strategies - newser.com
Applying sector rotation models to Artelo Biosciences Inc.Trade Analysis Summary & Verified Stock Trade Ideas - newser.com
Artelo Biosciences Enters Cooperation Agreement with Farb - The Globe and Mail
ETF Watch: Is Artelo Biosciences Inc. stock a defensive play in 2025Market Performance Report & Low Drawdown Investment Ideas - nchmf.gov.vn
How Artelo Biosciences Inc. stock valuations compare to rivalsWeekly Trend Recap & Fast Gaining Stock Reports - nchmf.gov.vn
Artelo Biosciences Inc Stock (ARTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):